A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis

相似書籍

• Absorption, Distribution, Metabolism, and Excretion of [(14)C]-Volixibat in Healthy Men: Phase 1 Open-Label Study
  由: Siebers, Nicholas, et al.
  出版: (2017)
• Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial
  由: Tiessen, Renger G., et al.
  出版: (2018)
• Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
  由: Klein, David J., et al.
  出版: (2014)
• Effects of cumin on nonalcoholic steatohepatitis: A double blind, randomised, controlled trial
  由: Shavakhi, Ahmad, et al.
  出版: (2015)
• Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects
  由: Kudiganti, Venkateshwarlu, et al.
  出版: (2016)